Fiorentino, F.P.; Marchesi, I.; Schröder, C.; Schmidt, R.; Yokota, J.; Bagella, L.
BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. Int. J. Mol. Sci. 2020, 21, 9595.
https://doi.org/10.3390/ijms21249595
AMA Style
Fiorentino FP, Marchesi I, Schröder C, Schmidt R, Yokota J, Bagella L.
BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 2020; 21(24):9595.
https://doi.org/10.3390/ijms21249595
Chicago/Turabian Style
Fiorentino, Francesco Paolo, Irene Marchesi, Christoph Schröder, Ronny Schmidt, Jun Yokota, and Luigi Bagella.
2020. "BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells" International Journal of Molecular Sciences 21, no. 24: 9595.
https://doi.org/10.3390/ijms21249595
APA Style
Fiorentino, F. P., Marchesi, I., Schröder, C., Schmidt, R., Yokota, J., & Bagella, L.
(2020). BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. International Journal of Molecular Sciences, 21(24), 9595.
https://doi.org/10.3390/ijms21249595